Clinical Trial Update: Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports results for the combination of photodynamic therapy and vismodegib in patients with multiple basal cell carcinomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: University of Arizona | Conditions: Basal Cell Carcinoma | Phase 1 | Status: COMPLETED